Skip to main content
Article thumbnail
Location of Repository

Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid a core independent.

By Neil J. Oldfield, A. P. Moran, Lorna A. Millar, M. M. Prendergast and Julian M. Ketley


Campylobacter jejuni produces both lipooligosaccharide (LOS) and a higher-molecular-weight polysaccharide that is believed to form a capsule. The role of these surface polysaccharides in C. jejuni-mediated enteric disease is unclear; however, epitopes associated with the LOS are linked to the development of neurological complications. In Escherichia coli and Salmonella enterica serovar Typhimurium the waaF gene encodes a heptosyltransferase, which catalyzes the transfer of the second l-glycero-d-manno-heptose residue to the core oligosaccharide moiety of lipopolysaccharide (LPS), and mutation of waaF results in a truncated core oligosaccharide. In this report we confirm experimentally that C. jejuni gene Cj1148 encodes the heptosyltransferase II enzyme, WaaF. The Campylobacter waaF gene complements an S. enterica serovar Typhimurium waaF mutation and restores the ability to produce full-sized lipopolysaccharide. To examine the role of WaaF in C. jejuni, waaF mutants were constructed in strains NCTC 11168 and NCTC 11828. Loss of heptosyltransferase activity resulted in the production of a truncated core oligosaccharide, failure to bind specific ligands, and loss of serum reactive GM1, asialo-GM1, and GM2 ganglioside epitopes. The mutation of waaF did not affect the higher-molecular-weight polysaccharide supporting the production of a LOS-independent capsular polysaccharide by C. jejuni. The exact structural basis for the truncation of the core oligosaccharide was verified by comparative chemical analysis. The NCTC 11168 core oligosaccharide differs from that known for HS:2 strain CCUG 10936 in possessing an extra terminal disaccharide of galactose-β(1,3) N-acetylgalactosamine. In comparison, the waaF mutant possessed a truncated molecule consistent with that observed with waaF mutants in other bacterial species.Peer-reviewedPublisher Versio

Publisher: American Society for Microbiology
Year: 2002
DOI identifier: 10.1128/JB.184.8.2100-2107.2002
OAI identifier:

Suggested articles


  1. (1994). A PCR-based strategy for the rapid construction of defined bacterial deletion mutants.
  2. (1982). A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. doi
  3. (2000). Animal models of Campylobacter infection, doi
  4. (1995). Antibody crossreactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. doi
  5. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. doi
  6. (2000). Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. doi
  7. (1996). Biosynthesis of inner core lipopolysaccharide in enteric bacteria identification and characterization of a conserved phosphoheptose isomerase. doi
  8. (2000). Campylobacter jejuni infection and the association with Guillain-Barré syndrome, doi
  9. (1999). Characterization of a WaaF (RfaF) homolog expressed by Haemophilus ducreyi.
  10. (1991). Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. doi
  11. (1999). Chemical structure of a polysaccharide from Campylobacter jejuni 176.83 (serotype O:41) containing only furanose sugars. doi
  12. (1993). Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. doi
  13. (1995). Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. doi
  14. (1993). Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. doi
  15. (1990). Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene 94:23–28. doi
  16. (1995). Cloning and molecular analysis of the Isi1 (rfaF) gene of Neisseria meningitidis which encodes a heptosyl-2-transferase involved in LPS biosynthesis: evaluation of surface exposed carbohydrates in LPS mediated toxicity for human endothelial cells. doi
  17. (1999). Cloning, mutation and distribution of a putative lipopolysaccharide biosynthesis locus in Campylobacter jejuni. doi
  18. (2001). Deciphering Campylobacter jejuni cell surface interactions from the genome sequence. doi
  19. (1997). Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. doi
  20. (1995). do not enter epithelial host cells. doi
  21. (1999). Evidence for a system of general protein glycosylation in Campylobacter jejuni. doi
  22. (1997). Expression of Campylobacter hyoilei lipo-oligosaccharide (LOS) antigens in Escherichia coli. doi
  23. Genetic and biochemical evidence of a Campylobacter jejuni capsular Gene 222:177–185.
  24. (1998). Genetic manipulation of enteric Campylobacter species, doi
  25. (1993). Genetics of lipopolysaccharide biosynthesis in enteric bacteria.
  26. (1986). Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates.
  27. (1998). Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide.
  28. (1997). Identification of the ADP-L-glycero-D-manno-heptose6-epimerase (rfaD) and heptosyltransferase II (rfaF) biosynthesis genes from nontypeable Haemophilus influenzae
  29. (2001). Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. doi
  30. (1994). Lipopolysaccharides of Campylobacter jejuni serotype O:19— structure of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barre syndrome. doi
  31. Molecular analysis of the rfaD gene, for heptose synthesis, and the rfaF gene, for heptose transfer, in lipopolysaccharide synthesis in Salmonella typhimurium.
  32. (1989). Molecular cloning: a laboratory manual, 2nd ed. doi
  33. (1990). Molecular structure of bacterial endotoxin in relation to bioactivity, doi
  34. (2000). Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide. doi
  35. (2001). Pathogenesis of enteric Campylobacter infection. doi
  36. (2000). Phase variation of a beta-1,3-galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. doi
  37. (1989). Rapid extraction of bacterial chrmosomal DNA with guanidinium thiocyanate. doi
  38. (1956). Reagent for differentiation of 1,4- and 1,6-linked glucosaccharides. doi
  39. (1999). Serotyping of Campylobacter jejuni based on heat-stable antigens: relevance, molecular basis and implications in pathogenesis. doi
  40. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. doi
  41. (1987). Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni.
  42. (1983). Studies on transformation of E. coli with plasmids. doi
  43. The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. doi
  44. (2000). The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. doi
  45. (1998). The lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116. doi
  46. (1996). Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. doi
  47. (1983). Water-borne outbreak of Campylobacter gastroenteritis. Lancet i:287–290. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.